NCT01181726View on ClinicalTrials.gov

Estradiol/Norethindrone Acetate Tablets, 1/0.5 mg Under Fed Conditions

PHASE1CompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

January 31, 2007

Primary Completion Date

February 28, 2007

Study Completion Date

February 28, 2007

Conditions
Healthy
Interventions
DRUG

Estradiol/Norethindrone acetate

1 mg/0.5 mg Tablets

DRUG

Activella®

1 mg/0.5 mg Tablets

Trial Locations (1)

M1L 4S4

Biovail Contract Research, Toronto

All Listed Sponsors
lead

Teva Pharmaceuticals USA

INDUSTRY

NCT01181726 - Estradiol/Norethindrone Acetate Tablets, 1/0.5 mg Under Fed Conditions | Biotech Hunter | Biotech Hunter